Get startedLog in
    Picture of China Shineway Pharmaceutical logo

    2877 — China Shineway Pharmaceutical Cashflow Statement

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareAdventurousMid CapSuper Stock
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for China Shineway Pharmaceutical, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line3957209171,2401,146
    Depreciation
    Amortisation
    Non-Cash Items116-98-126-120-145
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital-81.1-101133-365-106
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Accounts Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities6397031,110933963
    Capital Expenditures-66-93.6-129-144-140
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-2404898494.8-132
    Acquisition of Business
    Sale of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Change in Net Investments
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-306395-45.4-49.5-272
    Financing Cash Flow Items-54.61.17-0.63-2.6-6.27
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-330-829-250-26.7-392
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-3263821863251